Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 189307, 6 pages
http://dx.doi.org/10.1155/2015/189307
Research Article

Riluzole Stimulates BDNF Release from Human Platelets

Department of Morphological Sciences, Institute of Basic Health Sciences, Federal University of Rio Grande do Sul, Rua Sarmento Leite, 500, 90050-170 Porto Alegre, RS, Brazil

Received 1 July 2014; Accepted 17 September 2014

Academic Editor: Gianluca Coppola

Copyright © 2015 Patrick Türck and Marcos Emílio Frizzo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. R. Lewin and Y.-A. Barde, “Physiology of the neurotrophins,” Annual Review of Neuroscience, vol. 19, pp. 289–317, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. S. D. Croll, N. Y. Ip, R. M. Lindsay, and S. J. Wiegand, “Expression of BDNF and trkB as a function of age and cognitive performance,” Brain Research, vol. 812, no. 1-2, pp. 200–208, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Castrén, M. Pitkänen, J. Sirviö et al., “The induction of LTP increases BDNF and NGF mRNA but decreases NT-3 mRNA in the dentate gyrus,” NeuroReport, vol. 4, no. 7, pp. 895–898, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Jankowsky and P. H. Patterson, “Cytokine and growth factor involvement in long-term potentiation,” Molecular and Cellular Neurosciences, vol. 14, no. 6, pp. 273–286, 1999. View at Google Scholar · View at Scopus
  5. H. Yamamoto and M. E. Gurney, “Human platelets contain brain-derived neurotrophic factor,” Journal of Neuroscience, vol. 10, no. 11, pp. 3469–3478, 1990. View at Google Scholar · View at Scopus
  6. S. F. Radka, P. A. Holst, M. Fritsche, and C. A. Altar, “Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay,” Brain Research, vol. 709, no. 1, pp. 122–301, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Mori, K. Shimizu, and M. Hayashi, “Levels of serum brain-derived neurotrophic factor in primates,” Primates, vol. 44, no. 2, pp. 167–169, 2003. View at Google Scholar · View at Scopus
  8. R. Katoh-Semba, R. Wakako, T. Komori et al., “Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls,” International Journal of Developmental Neuroscience, vol. 25, no. 6, pp. 367–372, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. W. Pan, W. A. Banks, M. B. Fasold, J. Bluth, and A. J. Kastin, “Transport of brain-derived neurotrophic factor across the blood-brain barrier,” Neuropharmacology, vol. 37, no. 12, pp. 1553–1561, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Karege, M. Schwald, and M. Cisse, “Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets,” Neuroscience Letters, vol. 328, no. 3, pp. 261–264, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Lommatzsch, A. Braun, A. Mannsfeldt et al., “Abundant production of brain-derived neurotrophic factor by adult visceral epithelia: implications for paracrine and target-derived neurotrophic functions,” The American Journal of Pathology, vol. 155, no. 4, pp. 1183–1193, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Braun, M. Lommatzsch, A. Mannsfeldt et al., “Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation,” The American Journal of Respiratory Cell and Molecular Biology, vol. 21, no. 4, pp. 537–546, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. A. Gielen, M. Khademi, S. Muhallab, T. Olsson, and F. Piehl, “Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients,” Scandinavian Journal of Immunology, vol. 57, no. 5, pp. 493–497, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kerschensteiner, E. Gallmeier, L. Behrens et al., “Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?” Journal of Experimental Medicine, vol. 189, no. 5, pp. 865–870, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Watanabe, E. Hashimoto, W. Ukai et al., “Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 34, no. 8, pp. 1450–1454, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. P. Stoll, A. Plessow, K. Bratke, J. C. Virchow, and M. Lommatzsch, “Differential effect of clopidogrel and aspirin on the release of BDNF from platelets,” Journal of Neuroimmunology, vol. 238, no. 1-2, pp. 104–106, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. K. Toyooka, K. Asama, Y. Watanabe et al., “Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients,” Psychiatry Research, vol. 110, no. 3, pp. 249–257, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. K. B. Nelson, J. K. Grether, J. M. Dambrosia et al., “Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation,” Annals of Neurology, vol. 49, no. 5, pp. 597–606, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Miyazaki, N. Narita, R. Sakuta et al., “Serum neurotrophin concentrations in autism and mental retardation: a pilot study,” Brain & Development, vol. 26, no. 5, pp. 292–295, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. K. Hashimoto, Y. Iwata, K. Nakamura et al., “Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 30, no. 8, pp. 1529–1531, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. E. Shimizu, K. Hashimoto, N. Okamura et al., “Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants,” Biological Psychiatry, vol. 54, no. 1, pp. 70–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Karege, G. Perret, G. Bondolfi, M. Schwald, G. Bertschy, and J.-M. Aubry, “Decreased serum brain-derived neurotrophic factor levels in major depressed patients,” Psychiatry Research, vol. 109, no. 2, pp. 143–148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Karege, G. Bondolfi, N. Gervasoni, M. Schwald, J.-M. Aubry, and G. Bertschy, “Low Brain-Derived Neurotrophic Factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity,” Biological Psychiatry, vol. 57, no. 9, pp. 1068–1072, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. A. B. M. Cunha, B. N. Frey, A. C. Andreazza et al., “Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes,” Neuroscience Letters, vol. 398, no. 3, pp. 215–219, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. R. Machado-Vieira, M. O. Dietrich, R. Leke et al., “Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode,” Biological Psychiatry, vol. 61, no. 2, pp. 142–144, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. G. N. Pandey, Y. Dwivedi, H. S. Rizavi, X. Ren, H. Zhang, and M. N. Pavuluri, “Brain-derived neurotrophic factor gene and protein expression in pediatric and adult depressed subjects,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 34, no. 4, pp. 645–651, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. C. Pittenger and R. S. Duman, “Stress, depression, and neuroplasticity: a convergence of mechanisms,” Neuropsychopharmacology, vol. 33, no. 1, pp. 88–109, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. C. Zarate Jr., R. MacHado-Vieira, I. Henter, L. Ibrahim, N. Diazgranados, and G. Salvadore, “Glutamatergic modulators: the future of treating mood disorders?” Harvard Review of Psychiatry, vol. 18, no. 5, pp. 293–303, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. J. Mizoule, B. Meldrum, M. Mazadier et al., “2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—I: anticonvulsant properties,” Neuropharmacology, vol. 24, no. 8, pp. 767–773, 1985. View at Publisher · View at Google Scholar · View at Scopus
  30. S. J. Mathew, K. Keegan, and L. Smith, “Glutamate modulators as novel interventions for mood disorders,” Revista Brasileira de Psiquiatria, vol. 27, no. 3, pp. 243–248, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. S. J. Mathew, J. W. Murrough, M. Aan Het Rot, K. A. Collins, D. L. Reich, and D. S. Charney, “Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: A pilot randomized, placebo-controlled continuation trial,” International Journal of Neuropsychopharmacology, vol. 13, no. 1, pp. 71–82, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. G. Sanacora, S. F. Kendell, Y. Levin et al., “Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms,” Biological Psychiatry, vol. 61, no. 6, pp. 822–825, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. C. A. Zarate Jr., J. L. Payne, J. Quiroz et al., “An open-label trial of riluzole in patients with treatment-resistant major depression,” The American Journal of Psychiatry, vol. 161, no. 1, pp. 171–174, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. M. E. Frizzo, L. P. Dall'Onder, K. B. Dalcin, and D. O. Souza, “Riluzole enhances glutamate uptake in rat astrocyte cultures,” Cellular and Molecular Neurobiology, vol. 24, no. 1, pp. 123–128, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Katoh-Semba, T. Asano, H. Ueda et al., “Riluzole enhances expression of brain-derived neurotrophic factor with consequent proliferation of granule precursor cells in the rat hippocampus,” The FASEB Journal, vol. 16, no. 10, pp. 1328–1330, 2002. View at Google Scholar · View at Scopus
  36. I. Mizuta, M. Ohta, K. Ohta, M. Nishimura, E. Mizuta, and S. Kuno, “Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes,” Neuroscience Letters, vol. 310, no. 2-3, pp. 117–120, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Squitieri, S. Orobello, M. Cannella et al., “Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 7, pp. 1113–1120, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. R. M. Mangano and R. Schwarcz, “The human platelet as a model for the glutamatergic neuron: platelet uptake of L-glutamate,” Journal of Neurochemistry, vol. 36, no. 3, pp. 1067–1076, 1981. View at Publisher · View at Google Scholar · View at Scopus
  39. D. S. Rocha, S. K. Souza, T. G. H. Onsten, R. S. M. Silva, and M. E. Frizzo, “A simple method to quantify glycogen from human platelets,” Journal of Cytology & Histology, vol. 5, article 217, 2014. View at Publisher · View at Google Scholar
  40. Q. Niu, R. Zhang, M. Zhao et al., “Differences in platelet indices between healthy Han population and Tibetans in China,” PLoS ONE, vol. 8, no. 6, Article ID e67203, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. A. Arikanoglu, Y. Yucel, A. Acar et al., “The relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 13, pp. 1774–1777, 2013. View at Google Scholar · View at Scopus
  42. G. De Luca, G. G. Secco, M. Verdoia et al., “Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study,” Blood Coagulation and Fibrinolysis, vol. 25, no. 1, pp. 86–91, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. R. Ozdemir, C. Karadeniz, O. Doksoz et al., “Are mean platelet volume and platelet distribution width useful parameters in children with acute rheumatic carditis?” Pediatric Cardiology, vol. 35, no. 1, pp. 53–56, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. J.-L. Martin and C. Finsterwald, “Cooperation between BDNF and glutamate in the regulation of synaptic transmission and neuronal development,” Communicative & Integrative Biology, vol. 4, no. 1, pp. 14–16, 2011. View at Google Scholar · View at Scopus
  45. A. Rodriguez-Kern, M. Gegelashvili, A. Schousboe, J. Zhang, L. Sung, and G. Gegelashvili, “Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-κB,” Neurochemistry International, vol. 43, no. 4-5, pp. 363–370, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. C. V. Melo, M. Mele, M. Curcio, D. Comprido, C. G. Silva, and C. B. Duarte, “BDNF regulates the expression and distribution of vesicular glutamate transporters in cultured hippocampal neurons,” PLoS ONE, vol. 8, no. 1, Article ID e53793, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. P. Grant, J. Y. Song, and S. E. Swedo, “Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder,” Journal of Child and Adolescent Psychopharmacology, vol. 20, no. 4, pp. 309–315, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus